Craneware plc Board Appointment (5365J)
27 Abril 2022 - 9:00AM
UK Regulatory
TIDMCRW
RNS Number : 5365J
Craneware plc
27 April 2022
Craneware plc
("Craneware" or the "Company" or the "Group")
Board Appointment
27 April 2022 - Craneware (AIM: CRW.L), the market leader in
Value Cycle solutions for the US healthcare market, is pleased to
announce the appointment of Isabel ("Issy") Urquhart, Chief People
Officer, to the Board of Directors, with immediate effect.
Having joined Craneware in 2015, Issy is a valued member of the
Operation's Board of the Company and was instrumental in the
integration of the Sentry team following the acquisition last year.
In her role, Issy leads on the development and implementation of
HR, organisation design and development and change management
strategies. Previous roles include HR Director EMEA at CommScope, a
Fortune 500 organisation employing 30,000 employees worldwide and
Vice President of HR at Wolfson Microelectronics plc, a FTSE 350
Company. Issy is also prominent in the Scottish charitable and not
for profit spheres, in her roles as Vice-Chair of the Edinburgh
Business Beats Cancer Board and member of the Scottish and North
American Business Council.
Will Whitehorn, Chair of Craneware plc, commented ,
"Issy has been central in the successful integration of the
Sentry team into the Craneware Group and we are delighted to have a
leader with her skillset join the Board of Directors. Issy's
appointment reflects the importance we place on creating the right
environment for our people to thrive and the increased scale of the
Craneware Group."
Director Appointment Information
Issy Urquhart (née Houghton), aged 54, has an interest in 6,577
ordinary shares of 1p each in the Company ("Ordinary Shares"),
representing 0.02% of the issued share capital, 8,257 share options
to acquire Ordinary Shares and conditional awards of 25,686
Ordinary Shares under the Company's Long Term Incentive Plan.
There are no further disclosures required in accordance with AIM
Rule 17 and Schedule Two paragraph (g) of the AIM Rules for
Companies.
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Hilary Buchanan, Joe Pederzolli craneware@almapr.co.uk
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Dan Webster, Andrew Clark
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Henry Reast, Sebastian Lawrence
Berenberg (Joint Broker ) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff
About Craneware
We at the Craneware Group of companies, including our latest
additions Sentry Data Systems and Agilum Healthcare Intelligence,
passionately believe we can impact healthcare profoundly by
delivering the insights healthcare organizations need to also
transform the business of healthcare. Our shared vision is to be
the operational and financial partner for U.S. healthcare
providers.
Our combined suite of applications and industry-leading team of
experts help our customers contextualize operational, financial,
and clinical data, providing insights that clearly demonstrate what
great looks like. These value cycle insights deliver revenue
integrity and 340B compliance, as well as margin and operational
intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now
our customers, including more than 2000 U.S hospitals and health
systems and almost 10,000 clinics and retail pharmacies. Our
customers are operating with a financial impact of nearly half a
trillion dollars. We have data sets from customers covering more
than 150 million unique patients encounters.
Learn more at craneware.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAIRMLTMTJTMBT
(END) Dow Jones Newswires
April 27, 2022 08:00 ET (12:00 GMT)
Craneware (AQSE:CRW.GB)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Craneware (AQSE:CRW.GB)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025